Show simple item record

dc.contributor.authorPallasch, Christian
dc.contributor.authorBraun, Christian Joerg
dc.contributor.authorHemann, Michael
dc.contributor.authorPavlova, Natalya N.
dc.contributor.authorElia, Andrew E. H.
dc.contributor.authorWestbrook, Thomas F.
dc.contributor.authorElledge, Stephen J.
dc.date.accessioned2014-01-24T19:59:31Z
dc.date.available2014-01-24T19:59:31Z
dc.date.issued2013-04
dc.date.submitted2012-10
dc.identifier.issn2050-084X
dc.identifier.urihttp://hdl.handle.net/1721.1/84514
dc.description.abstractDuring all stages of tumor progression, cancer cells are subjected to inappropriate extracellular matrix environments and must undergo adaptive changes in order to evade growth constraints associated with the loss of matrix attachment. A gain of function screen for genes that enable proliferation independently of matrix anchorage identified a cell adhesion molecule PVRL4 (poliovirus-receptor-like 4), also known as Nectin-4. PVRL4 promotes anchorage-independence by driving cell-to-cell attachment and matrix-independent integrin β4/SHP-2/c-Src activation. Solid tumors frequently have copy number gains of the PVRL4 locus and some have focal amplifications. We demonstrate that the transformation of breast cancer cells is dependent on PVRL4. Furthermore, growth of orthotopically implanted tumors in vivo is inhibited by blocking PVRL4-driven cell-to-cell attachment with monoclonal antibodies, demonstrating a novel strategy for targeted therapy of cancer.en_US
dc.language.isoen_US
dc.publishereLife Sciences Publications, Ltd.en_US
dc.relation.isversionofhttp://dx.doi.org/10.7554/eLife.00358en_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/en_US
dc.sourcePMCen_US
dc.titleA role for PVRL4-driven cell-cell interactions in tumorigenesisen_US
dc.typeArticleen_US
dc.identifier.citationPavlova, N. N., C. Pallasch, A. E. Elia, C. J. Braun, T. F. Westbrook, M. Hemann, and S. J. Elledge. “A role for PVRL4-driven cell-cell interactions in tumorigenesis.” eLife 2, no. 0 (January 8, 2013): e00358-e00358.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorPallasch, Christianen_US
dc.contributor.mitauthorBraun, Christian Joergen_US
dc.contributor.mitauthorHemann, Michaelen_US
dc.relation.journaleLifeen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsPavlova, N. N.; Pallasch, C.; Elia, A. E.; Braun, C. J.; Westbrook, T. F.; Hemann, M.; Elledge, S. J.en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-5229-8748
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record